Ahn SH - Search Results

1

Sorafenib versus cytotoxic chemotherapy for patients with advanced hepatocellular carcinoma: a retrospective, single-institution study.

Lee S, Yoon SH, Park JY, Kim DY, Ahn SH, Han KH, Choi HJ. Lee S, et al. Among authors: ahn sh. Invest New Drugs. 2012 Jun;30(3):1150-7. doi: 10.1007/s10637-011-9634-4. Epub 2011 Jan 20. Invest New Drugs. 2012. PMID: 21249514

2

[Concurrent chemo-radiation therapy for advanced hepatocellular carcinoma with portal vein thrombosis].

Kim JS, Han KH, Lee DY, Seong JS, Youn YH, Cheong JY, Ahn SH, Chon CY, Moon YM. Kim JS, et al. Among authors: ahn sh. Taehan Kan Hakhoe Chi. 2002 Mar;8(1):71-9. Taehan Kan Hakhoe Chi. 2002. PMID: 12499819 Clinical Trial. Korean.

3

Evolution of hepatitis B virus sequence from a liver transplant recipient with rapid breakthrough despite hepatitis B immune globulin prophylaxis and lamivudine therapy.

Kim KH, Lee KH, Chang HY, Ahn SH, Tong S, Yoon YJ, Seong BL, Kim SI, Han KH. Kim KH, et al. Among authors: ahn sh. J Med Virol. 2003 Nov;71(3):367-75. doi: 10.1002/jmv.10503. J Med Virol. 2003. PMID: 12966541

4

Hepatitis B virus infection after renal transplantation in the presence of antibody to hepatitis B surface antigen immunity.

Kim KH, Ahn SH, Chung HY, Paik YH, Lee KS, Kim YS, Chon CY, Moon YM, Han KH. Kim KH, et al. Among authors: ahn sh. J Gastroenterol Hepatol. 2004 Aug;19(8):847-53. doi: 10.1111/j.1440-1746.2003.03303.x. J Gastroenterol Hepatol. 2004. PMID: 15242485

5

Treatment outcome of transcatheter arterial chemoinfusion according to anticancer agents and prognostic factors in patients with advanced hepatocellular carcinoma (TNM stage IVa).

Ahn SH, Han KH, Park JY, Youn YH, Moon CM, Lee KS, Chon CY, Moon YM, Lee DY, Lee JT. Ahn SH, et al. Yonsei Med J. 2004 Oct 31;45(5):847-58. doi: 10.3349/ymj.2004.45.5.847. Yonsei Med J. 2004. PMID: 15515195 Free article.

6

[Reappraisal of HBV genotypes and clinical significance in Koreans using MALDI-TOF mass spectrometry].

Lee JM, Ahn SH, Chang HY, Shin JE, Kim DY, Sim MK, Hong SP, Chung HJ, Kim SO, Han KH, Chon CY, Moon YM. Lee JM, et al. Among authors: ahn sh. Korean J Hepatol. 2004 Dec;10(4):260-70. Korean J Hepatol. 2004. PMID: 15613801 Korean.

7

Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance.

Ahn SH, Park YN, Park JY, Chang HY, Lee JM, Shin JE, Han KH, Park C, Moon YM, Chon CY. Ahn SH, et al. J Hepatol. 2005 Feb;42(2):188-94. doi: 10.1016/j.jhep.2004.10.026. J Hepatol. 2005. PMID: 15664243

8

How to predict HCC development in patients with chronic B viral liver disease?

Han KH, Ahn SH. Han KH, et al. Among authors: ahn sh. Intervirology. 2005;48(1):23-8. doi: 10.1159/000082091. Intervirology. 2005. PMID: 15785086

9

Evaluation of methods for monitoring drug resistance in chronic hepatitis B patients during lamivudine therapy based on mass spectrometry and reverse hybridization.

Kim HS, Han KH, Ahn SH, Kim EO, Chang HY, Moon MS, Chung HJ, Yoo W, Kim SO, Hong SP. Kim HS, et al. Among authors: ahn sh. Antivir Ther. 2005;10(3):441-9. Antivir Ther. 2005. PMID: 15918335

10

[Association between CCR5 promoter polymorphisms and hepatitis B virus infection].

Chang HY, Ahn SH, Kim DY, Shin JS, Kim YS, Hong SP, Chung HJ, Kim SO, Yoo WD, Han KH. Chang HY, et al. Among authors: ahn sh. Korean J Hepatol. 2005 Jun;11(2):116-24. Korean J Hepatol. 2005. PMID: 15980670 Korean.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,479 results

Search Page

Filters